Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| ROIV | CLUSTER | neutral | 3/10 | Two top executives at Roivant Sciences (President & CIO and President & Immunovant CEO) sold a total of $22.15M in open- | Jun 29, 2026 |
| PHVS | CLUSTER | neutral | 3/10 | Insider cluster at Pharvaris N.V. shows two insiders selling shares totaling $584K (0.024% of market cap), with the CMO' | Jun 29, 2026 |
| CYTK | CLUSTER | neutral | 2/10 | CFO Lee Sung and EVP R&D Fady Ibraham sold shares worth $3.47M combined, but this represents only 0.034% of CYTK's $10.2 | Jun 29, 2026 |
| SYRE | CLUSTER | bearish | 7/10 | A massive insider selling cluster at Spyre Therapeutics (SYRE) saw $402M in open-market sales over four days, led by dir | Jun 26, 2026 |
| IMVT | CLUSTER | neutral | 2/10 | Five Immunovant insiders (CFO, COO, CTO, CLO, and a director) sold a combined $2.85M in open-market shares on June 26, 2 | Jun 26, 2026 |
| IONS | CLUSTER | neutral | 2/10 | CEO Monia Brett P and EVP Research Eric Swayze sold a combined ~$7.7M in open-market sales over a 3-day window, primaril | Jun 26, 2026 |
| KYMR | CLUSTER | bearish | 6/10 | A significant insider selling cluster at Kymera Therapeutics, led by director BVF Partners' $89.2M open-market sale, tot | Jun 26, 2026 |
| PTCT | CLUSTER | neutral | 2/10 | Three PTCT insiders sold a total of $2.04M in shares over a week, representing only 0.03% of the $7B market cap. The sal | Jun 26, 2026 |
| INSM | CLUSTER | neutral | 2/10 | Two INSM insiders, including the CEO, sold a combined $1.41M in shares over June 22-25, 2026. The total represents only | Jun 26, 2026 |
| GLUE | CLUSTER | neutral | 2/10 | A cluster of insider sales and option exercises at Monte Rosa Therapeutics over the past week saw Chief Medical Officer | Jun 26, 2026 |
| TWST | CLUSTER | neutral | 2/10 | Three Twist Bioscience insiders, including CEO Emily Leproust, sold a combined $203K in open-market transactions on June | Jun 25, 2026 |
| KRRO | CLUSTER | bearish | 6/10 | Multiple insiders at Korro Bio sold shares totaling $2.3M over a 10-day window, led by director Jean Francois Formela wh | Jun 24, 2026 |
| APGE | CLUSTER | neutral | 6/10 | Two top insiders (CEO and CMO) sold a total of $14.1M in open-market transactions on June 22, 2026, just days after the | Jun 24, 2026 |
| EVMN | CLUSTER | neutral | 3/10 | Two C-suite insiders at Evommune (CEO and CSO) sold a combined $202K in open-market sales on June 22, 2026. The total re | Jun 24, 2026 |
| CAPR | CLUSTER | neutral | 2/10 | Two Capricor Therapeutics insiders (CFO and EVP General Counsel) sold a combined $30K in open-market shares on June 22 a | Jun 24, 2026 |
| SYRE | CLUSTER | bearish | 7/10 | Two directors at Spyre Therapeutics executed massive open-market sales totaling $401.66M in a 7-day window, with the lar | Jun 23, 2026 |
| CBIO | CLUSTER | neutral | 4/10 | Seven insiders at Crescent BioPharma, including CEO Joshua Brumm and President/COO Jonathan McNeill, sold shares on June | Jun 23, 2026 |
| KYMR | CLUSTER | neutral | 3/10 | Two Kymera insiders (Director Bruce Booth and CBO Noah Goodman) sold a combined $1.62M in open-market shares over a 7-da | Jun 22, 2026 |
| ORKA | CLUSTER | neutral | 3/10 | Five Oruka Therapeutics insiders, including the CEO, CMO, COO, General Counsel, and SVP Finance, sold a total of $396K i | Jun 22, 2026 |
| CRDF | CLUSTER | bullish | 4/10 | Two insiders at Cardiff Oncology, including the CEO, made open-market purchases totaling $66K on June 18, 2026. While th | Jun 22, 2026 |
| CSTL | CLUSTER | neutral | 2/10 | Two insiders at Castle Biosciences sold a combined $189K in open-market transactions over two days. The CEO's sale was s | Jun 19, 2026 |
| PCVX | CLUSTER | neutral | 3/10 | Two top C-suite executives at Vaxcyte (CEO and CFO) sold a combined ~$542K in open-market sales on June 18, 2026, follow | Jun 18, 2026 |
| ADTX | CLUSTER | bearish | 7/10 | A mixed insider cluster at Aditxt shows HRT Financial LP buying ~$98K in shares, while DRW Securities sold a trivial amo | Jun 18, 2026 |
| LGND | CLUSTER | neutral | 3/10 | Four LGND directors sold shares in a cluster totaling ~$2.5M in open-market sales following option exercises. The sales | Jun 18, 2026 |
| NRSN | CLUSTER | bullish | 6/10 | CEO Alon Ben-Noon and CFO Or Eisenberg each purchased $200K worth of NRSN shares on June 16, 2026, at $0.80 per share, t | Jun 18, 2026 |
| MLYS | CLUSTER | neutral | 2/10 | Two insiders at Mineralys Therapeutics (MLYS) sold a combined $310K in open-market transactions over a 7-day window. The | Jun 17, 2026 |
| ARQT | CLUSTER | neutral | 2/10 | Two directors at Arcutis Biotherapeutics sold a combined $221K in open-market transactions over a 7-day window. The tota | Jun 17, 2026 |
| ADPT | CLUSTER | neutral | 3/10 | ADPT's Chief Scientific Officer sold $1.85M of stock in two open-market transactions within a week, the cluster's only a | Jun 17, 2026 |
| PTHS | CLUSTER | bullish | 6/10 | Director Todd C. Davis purchased $986K of PTHS stock at $27.80, representing ~1% of market cap, while another director s | Jun 17, 2026 |
| ABOS | CLUSTER | neutral | 2/10 | Two directors at Acumen Pharmaceuticals sold a combined $29K in open-market shares over a 7-day window, representing ~0. | Jun 17, 2026 |